The Lancet's COVID-19 Resource Centre: an open letter warning about the herd immunity approach to managing COVID-19, and more.

New COVID-19 Content is Now Available

Dear Victor Norberto,

Editor's Pick: In a Correspondence, published in The Lancet, a group of 80 researchers warn that a so-called herd immunity approach to managing COVID-19 by allowing immunity to develop in low-risk populations while protecting the most vulnerable is “a dangerous fallacy unsupported by the scientific evidence”. Faced with a second wave of COVID-19, and more than a million recorded deaths worldwide, the authors present their view of the evidence-based consensus on COVID-19. Read the Correspondence here.

The letter, initially signed by 80 international researchers, now has more than 2,000 verified signatures since its launch yesterday at the 16th World Congress on Public Health with a call for the scientific community to show their support by signing the John Snow Memorandum, which you can access here.

We hope you find the Resource Centre on COVID-19 to be informative. 

Yours sincerely,

The Lancet

NEW content on COVID-19

The Lancet Nursing's seat at the research roundtable Maternal and child mortality worsens in Latin America and the Caribbean SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates Scientific consensus on the COVID-19 pandemic: we need to act now The Lombardy region of Italy launches the first investigative COVID-19 commission The Lancet Child & Adolescent Health Coping with more than COVID-19 The Lancet Digital Health Epidemiological changes on the Isle of Wight after the launch of the NHS Test and Trace programme: a preliminary analysis Open Access Towards better contact-tracing in the UK Open Access The Lancet Gastroenterology & Hepatology Research in brief The Lancet Global Health Developing health policies in patients presenting with SARS-CoV-2: consider tuberculosis Open Access The Lancet Infectious Diseases Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial A promising inactivated whole-virion SARS-CoV-2 vaccine The Lancet Psychiatry COVID-19 policies in the UK and consequences for mental health Characterising neuropsychiatric disorders in patients with COVID-19 Characterising neuropsychiatric disorders in patients with COVID-19 Characterising neuropsychiatric disorders in patients with COVID-19 – Authors' reply Reducing alcohol misuse during the COVID-19 pandemic in Kenya The Lancet Public Health Impact of COVID-19 mitigation measures on the incidence of preterm birth: a national quasi-experimental study Open Access COVID-19 in New Zealand and the impact of the national response: a descriptive epidemiological study Open Access Lessons from New Zealand's COVID-19 outbreak response Open Access EClinicalMedicine Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study Open Access Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort) Open Access Evaluation of PEEP and prone positioning in early COVID-19 ARDS Open Access The menacing assaults on science, FDA, CDC, and health of the US public Open Access A case-control and cohort study to determine the relationship between ethnic background and severe COVID-19 Open Access Tuberculosis and COVID-19 in Canada Open Access